A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Celgene
Istari Oncology, Inc.
Bexion Pharmaceuticals, Inc.
Lumos Pharma
INSYS Therapeutics Inc
Novartis
Eli Lilly and Company